跳至主要内容
临床试验/CTRI/2008/091/000154
CTRI/2008/091/000154已完成4 期

A open-labelled, prospective, randomized, two-arm, parallel group 4-week clinical study to assess efficacy & safety of doxophylline extended release 800 mg OD vs doxophylline 400 mg BD in the treatment of patients with chronic obstructive pulmonary disease.

German Remedies Division, Cadila Healthcare Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients ³40 years, (male or non-pregnant female)
  • Clinical diagnosis of stable COPD

排除标准

  • Patients with severe COPD requiring oxygen therapy, COPD exacerbation in the 4 weeks prior to screening visit or untreated serious respiratory infectious disease
  • History of hypersensitivity methylxanthines, doxofylline or any ingredients of study formulations
  • History of asthma, allergic rhinitis, atopy, or an elevated blood eosinophil count
  • Recent history of myocardial infarction, heart failure, or cardiac arrhythmia requiring treatment and uncontrolled hypertension, severe renal or hepatic disease, active peptic ulcer disease
  • Pregnant or breastfeeding females
  • Patients already part or being a part of any clinical study in previous 1 months
  • Any reasons at the discretion of investigators does not allow patients to participate in study

研究者

发起方
German Remedies Division, Cadila Healthcare Limited

相似试验

Study to assess efficacy & safety of doxofylline... | 临床试验